# Treatment of Erectile Dysfunction II

> **NCT01037218** · PHASE3 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 601 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Udenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01037218
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2015-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037218, "Treatment of Erectile Dysfunction II". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01037218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
